---
title: "BioEurope – Vienna"
id: "1642"
type: "post"
slug: "bioeurope-vienna"
published_at: "2025-09-05T06:58:25+00:00"
modified_at: "2025-09-08T11:10:43+00:00"
url: "https://innocorepharma.com/news-events/bioeurope-vienna/"
markdown_url: "https://innocorepharma.com/news-events/bioeurope-vienna.md"
taxonomy_category:
  - "Events"
---

Vienna, 3 - 5 November 2025

# BioEurope – Vienna

# Meet InnoCore Pharmaceuticals at BioEurope 2025 – Advance Your API into a Long-Acting Injectable

InnoCore Pharmaceuticals is excited to attend [BioEurope 2025](https://informaconnect.com/bioeurope/)
, where you can connect with our team to explore our cutting-edge solutions to advance your API into a long-acting injectable.

[Vincent de Boer](https://innocorepharma.com/company/people/vincent-de-boer/)
, Business Development Manager, and [Martin Bakker](https://innocorepharma.com/company/people/martin-bakker/)
, Chief Business Officer, will be on site to discuss how our [SynBiosys®](https://innocorepharma.com/technologies/synbiosys/)
 polymer platform enables the development of biodegradable long-acting injectables—without the typical limitations of aggregation, acylation, or high local pH.

## Next-Generation injectables with Synbiosys

Whether you’re aiming to reduce dosing frequency or transition from IV to subQ administration, our technology offers tailored, tunable release profiles for peptides, proteins, and other biologics.

### Why partner with InnoCore Pharmaceuticals?

• Extensive expertise in sustained-release formulations

• Proven track record in developing bespoke long-acting injectable formulations for peptides, proteins, and other biologics

• Tunable [SynBiosys](https://innocorepharma.com/technologies/synbiosys/)
® polymer platform to develop formulations with 1 week or several months sustained release systems; dependable on your needs

• Strong collaborative approach from early-stage development through to clinical supply

#### Arrange a meeting during the BioEurope!

We would love to discuss how our drug delivery technologies can support your development goals. You can connect with Martin or Vincent through the BioEurope partnering platform, reach out to us directly via the contact form below, or contact us on: [+31 50 575 3100](tel:+31%2050%20575%203100)

"*" indicates required fields

Related insights

[Boston, 27 & 28 October 2025 Partnerships in drug delivery – Boston Join Rob Steendam, at his talk on “SynBiosys®: Long-Acting Injectable Microspheres and In Situ Forming Depots for Delivery of Peptides and Proteins”! Read the full story](https://innocorepharma.com/news-events/partnerships-in-drug-delivery-boston/)
[01 December 2024 | Innovation & Research Award of EU grant and Joins Research Consortium focused in brain diseases Innocore has been awarded an EU grant and Joins Research Consortium focused in brain diseases withh argeted drug delivery across the blood-brain barrier. Read the full story](https://innocorepharma.com/news-events/innocore-awarded-eu-grant-focused-on-brain-diseases/)
[Boston, 15 - 16 September 2025 Drug Delivery & Formulation Summit – Boston Our expert Aiva Simaite is eager to present at the DDF Summit in Boston! Read the full story](https://innocorepharma.com/news-events/drug-delivery-formulation-summit-boston/)